Displaying 1 - 12 of 13
Viral Hepatitis
1

GSK: Time to rethink chronic hepatitis B: Quantitative hepatitis B surface antigen today and tomorrow (Complete Session) - EASL Congress 2024

View
Viral Hepatitis
1

GSK: Time to rethink chronic hepatitis B: A roadmap to functional cure (Complete Session) - EASL Congress 2024

View
Viral Hepatitis
6

AbbVie: Don’t Delay, Let Test and Treat Lead the HCV Elimination Way! - EASL Congress 2024

View
Viral Hepatitis
6

AbbVie: Don’t Delay, Let Test and Treat Lead the HCV Elimination Way! - EASL Congress 2024

View
Viral Hepatitis
6

AbbVie: Don’t Delay, Let Test and Treat Lead the HCV Elimination Way! - EASL Congress 2024

View
Viral Hepatitis
6

AbbVie: Don’t Delay, Let Test and Treat Lead the HCV Elimination Way! - EASL Congress 2024

View
Viral Hepatitis
6

AbbVie: Don’t Delay, Let Test and Treat Lead the HCV Elimination Way! - EASL Congress 2024

View
Viral Hepatitis
6

AbbVie: Don’t Delay, Let Test and Treat Lead the HCV Elimination Way! - EASL Congress 2024

View
Viral Hepatitis
5

Biotest: "Decoding the Best Strategies for Post-Transplant HBV Recurrence Prevention" - EASL Congress 2024

View
Viral Hepatitis
5

Biotest: "Decoding the Best Strategies for Post-Transplant HBV Recurrence Prevention" - EASL Congress 2024

View
Viral Hepatitis
5

Biotest: "Decoding the Best Strategies for Post-Transplant HBV Recurrence Prevention" - EASL Congress 2024

View
Viral Hepatitis
5

Biotest: "Decoding the Best Strategies for Post-Transplant HBV Recurrence Prevention" - EASL Congress 2024

View